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Abstract
Golgi phosphoprotein 2 (GOLPH2) is a resident Golgi type-II membrane protein upregulated in liver disease. Given that
GOLPH2 traffics through endosomes and can be secreted into the circulation, it is a promising serum marker for liver
diseases. The structure of GOLPH2 and the functions of its different protein domains are not known. In the current study, we
investigated the structural determinants for Golgi localization using a panel of GOLPH2 truncation mutants. The Golgi
localization of GOLPH2 was not affected by the deletion of the C-terminal part of the protein. A truncated mutant
containing the N-terminal portion (the cytoplasmic tail and transmembrane domain (TMD)) localized to the Golgi.
Sequential deletion analysis of the N-terminal indicated that the TMD with a positively charged residue in the cytoplasmic
N-terminal tail were sufficient to support Golgi localization. We also showed that both endogenous and secreted GOLPH2
exist as a disulfide-bonded dimer, and the coiled-coil domain was sufficient for dimerization. This structural knowledge is
important for the understanding the pathogenic role of GOLPH2 in liver diseases, and the development of GOLPH2-based
hepatocellular cancer diagnostic methods.
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Introduction
Golgi phosphoprotein 2 (GOLPH2, also termed GP73 and
GOLM1) is a type II transmembrane protein residing in the cis
and medial-Golgi cisternae. GOLPH2 is predominantly expressed
in the epithelial cells of many human tissues [1]. Abnormally
increased expression of GOLPH2 has been reported to correlate
with many diseases and viral infections. GOLPH2 overexpression
has first been identified in acute giant-cell hepatitis, an uncommon
form of hepatitis with a presumed viral etiology [1], and then in a
variety of acute and chronic liver diseases [2,3,4,5]. Fucosylated
glycosylation has also been found in three quarters of secreted
GOLPH2 from hepatocellular carcinoma patients [6]. Earlier
studies have indicated that both the serum level of GOLPH2 and
fucos-studded GOLPH2 could be a more reliable biomarkers for
the early diagnosis of liver diseases than current markers like
alpha-fetoprotein [7,8].
Despite its potential as a biomarker for liver disease, knowledge
on the structure and function of GOLPH2 remains very limited.
Sequence analysis shows that GOLPH2 is highly conserved in
vertebrates. It has a short N-terminal cytoplasmic domain followed
by a transmembrane domain (TMD), and a longer C-terminal
domain located in the Golgi lumen with a coiled-coil domain
immediately beside the TMD [1]. To determine the possible
physiological role of GOLPH2, Wright et al. constructed a
transgenic mouse model with part of the GOLPH2 C-terminal
truncated. GP73
tr/tr mice exhibited decreased survival and severe
epithelial abnormalities in the liver and kidneys, suggesting that
GOLPH2 may play an important role in epithelial cell function in
these organs [9].
Being a type II transmembrane protein, GOLPH2 is unlikely to
be a secreted protein. A possible explanation for its secretion
comes from the observations that GOLPH2 is capable of
intracellular trafficking between the Golgi and plasma membrane
through an endosomal pathway, as well as the existence of a
conserved proprotein protease cleavage site (R
52VRR
55) [10].
Cleavage by cellular proprotein convertase results in the secretion
of the Golgi luminal portion of GOLPH2. The level of this
proteolytic cleavage is speculated to be correlated with the level of
GOLPH2 abnormal overexpression [10]. However, details on the
structural determinants for GOLPH2 Golgi localization and
intracellular trafficking are not clear.
The subcellular localization of Golgi proteins is signal
dependent. Many type II membrane proteins with a short
cytoplasmic tail contain a Golgi retention signal in or around
their TMDs [11,12,13]. Two different models are proposed for
Golgi localization. The oligomerization model posits that the
formation of oligomers prevents protein movement into transport
vesicles. In contrast, the bilayer-thickness model suggests that a
short TMD restricts the protein to the thinner lipid bilayer of the
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e28207Golgi, whereas a longer TMD allows the protein to be localized to
the thicker lipid bilayer of the plasma membrane [14,15].
To illustrate the structural determinants of GOLPH2 Golgi
localization and its oligomeric status, a panel of GOLPH2
truncation mutants was constructed in the present study. Our
data showed that the short N-terminal cytoplasmic tail and TMD
were not only responsible for GOLPH2 intracellular trafficking
and secretion, but were also required for the Golgi localization of
GOLPH2. Our study also suggested that this Golgi localization
depended on a positively charged residue at the cytoplasmic end,
and on the length of the TMD. We found as well that both
intracellular and secreted GOLPH2 exist as disulfide-bonded
dimers mediated via the coiled-coil domain. Given that GOLPH2
is a promising marker for liver diseases, a detailed understanding
of its function and structure could provide mechanistic insights
into the pathogenesis of GOLPH2-related diseases.
Results
The N-terminal cytoplasmic tail and TMD are important
for GOLPH2 trafficking
Based on the predicted secondary structure and the level of
sequence conservations(Figure S1 and Figure S2), we divided
GOLPH2 into five regions (Figure 1A and Table 1). To initiate the
structural-functional analysis of GOLPH2, we constructed
GOLPH2 truncation mutants (Figure 1B). Previous studies have
demonstrated that the intracellular trafficking of GOLPH2 via
endosomes is closely associated with secretion when protein
expression is upregulated [10]. To determine the important
structural elements determining intracellular trafficking and
secretion, we first measured the secretion level of GOLPH2
truncation mutants using the quantitative enzyme-linked immu-
nosorbent assay (ELISA) for GOLPH2 [5]. As indicated in
Figure 1. Schematic diagrams of GOLPH2 truncation mutants. A. Structural regions of GOLPH2. Based on sequence and structure
analyses, GOLPH2 is divided into five regions: region I (cytoplasmic tail), region II (transmembrane domain), region III (coiled-coil domain), region IV,
and region V (conserved domain of C-terminal). Five potential glycosylation sites are presented, namely, three N-linked glycosylation sites (N109,
N144, and N398) and two O-linked glycosylation sites (T218 and T235). B. GOLPH2 truncation mutants. Different regions of GOLPH2 were
amplified by PCR and cloned into pCR3.1 vector with an in-frame FLAG-tag encoded at the C-terminal to construct the GOLPH2 truncated mutants. A
BamH I site was introduced into GOLPH2-D(IV–V) and GOLPH2-DI by point mutation. The EGFP coding region was cloned into GOLPH2-D(IV–V) and
GOLPH2-DI in site with BamH I and EcoR I to generate GOLPH2-D(III–IV–V) and GOLPH2-D(I–III–IV–V) mutants.
doi:10.1371/journal.pone.0028207.g001
GP73 Dimerization and Golgi Localization Signal
PLoS ONE | www.plosone.org 2 November 2011 | Volume 6 | Issue 11 | e28207Figure 2A, the overexpression of full-length GOLPH2-FL and
GOLPH2-DV resulted in a significantly increased secretion.
However, compared with GOLPH2-FL and GOLPH2-DV, a
significantly decreased secretion was observed in all mutants with
region I deletions (GOLPH2-DI, GOLPH2-D(I-V), and
GOLPH2-D(I-II)). These results suggested the importance of the
Table 1. Regions of GOLPH2.
Region No. AA No. Subcellular localization, predicted structure, conservation
I 1–12 Cytoplasm localized. Conserved. M1-S10 does not exist in some isoforms (UniProt # QBNBJ4).
II 13–35 Transmembrane domain. Conserved.
III 36–205 Golgi luminal. Coiled-coil. Conserved.
IV 206–348 Golgi luminal. None structured. Diversified.
V 349–401 Golgi luminal. Conserved.
Based on the sequence and structure analysis, GOLPH2 is divided into five regions. The amino acid sequence number and predicted structure is shown.
doi:10.1371/journal.pone.0028207.t001
Figure 2. The TMD and cytoplasmic tail are important for GOLPH2 intracellular trafficking. A. Secretion assay of GOLPH2
truncation proteins in HeLa cells. HeLa cells were transfected with GOLPH2 truncation expression plasmids. The medium was collected and
secreted GOLPH2 was analyzed by sandwich ELISA. Data are normalized to control plasmids. Bars show mean and error bars show 95% CI of mean.
n=6,*p,0.01. B. Cell surface presentation of GOLPH2 truncation proteins in HeLa cells. About 48 h after transfection, HeLa cells were
collected and resuspended. The cell surface distribution of GOLPH2 truncation proteins was analyzed by flow cytometry using anti-FLAG mAb. Data
are normalized to control plasmids. Bars show mean and error bars show 95% CI of mean. n=6, *p,0.01. C. Expression level of GOLPH2
truncation proteins. About 48 h after transfection, HeLa cells were collected and subjected to SDS PAGE followed by western blot. The expression
level of GOLPH2 truncation proteins was detected with Western-blot using anti-FLAG mAb. The molecular weight marker is shown on the left.
doi:10.1371/journal.pone.0028207.g002
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secretion.
A previous study has suggested that GOLPH2 could be
transiently presented to the cell surface during trafficking [10].
In the present study, we determined whether cell surface
presentation was also affected by truncation. Consistent with the
protein secretion changes above described, when HeLa cells were
transfected with plasmids for GOLPH2-FL, GOLPH2-DV, and
GOLPH2-D(IV–V), there was an increased cytoplasmic mem-
brane presentation of the expressed proteins (Figure 2B). However,
for the region I deletion mutants (GOLPH2-DI, GOLPH2-D(I–V),
and GOLPH2-D(I–II)), no evident change was observed, even
though a similar expression level of recombinant proteins was
readily detected from whole cell lysates (Figure2C). Therefore,
mutants with both the N-terminal cytoplasmic tail and the TMD
deleted failed to transport to or localize on the cell surface.
The TMD and cytoplasmic tail of GOLPH2 determine its
Golgi localization
To determine the intracellular localization of these mutant
proteins, plasmids encoding C-terminal FLAG-tagged GOLPH2
truncation mutants were transiently transfected into HeLa cells.
The cellular localization of the recombinant proteins was then
determined. b-1,4-galactosyltransferase (GalT) fused with cyan
fluorescent protein (a gift from Dr. Jun Yuan of the Harvard
Medical School, Boston, MA) at the C-terminal was used as a
Golgi membrane marker [16]. As shown in Figure 3A, GOLPH2-
FL, GOLPH2-DV, and GOLPH2-D(IV–V) colocalized with GalT
in the Golgi. On the other hand, GOLPH2-DI showed dispersed
localization within the cytoplasm. These results suggested that the
Golgi localizing signal was located within regions I, II, and III.
To determine the location of the Golgi targeting signal for
GOLPH2, two C-terminal EGFP fusion proteins were construct-
ed. These proteins contained regions I and II of GOLPH2
(GOLPH2-D(III–IV–V)) and only region II (GOLPH2-D(I–III–
IV–V)). Their cellular localizations were compared with endog-
enous GOLPH2 using the Leica Confocal Software. As shown in
Figure 3B, GOLPH2-D(III–IV–V) retained Golgi localization,
whereas GOLPH2-D(I–III–IV–V) became localized to the cyto-
plasm. When the localization of GOLPH2-D(I–III–IV–V) and
GOLPH2-DI were compared with calreticulin (an endoplasmic
reticulum (ER) marker protein), both truncated proteins were
localized to the ER. These results indicated that regions I (12
amino acids) and II (23 amino acids) were sufficient to support
protein Golgi localization, whereas region III is not required.
The Golgi retention signal is in the TMD of GOLPH2, and
requires a positively charged residue at the cytoplasmic
end
Since the cytoplasm region of GOLPH2 (region I) is a conserved
12-amino acid polypeptide, we wondered if specific sequences in
this region were required to support the Golgi localization of
GOLPH2. To answer this question, we first generated two amino
acid replacement mutants of the region I portion of GOLPH2-
D(III–IV–V)-EGFP. Two arginine (Arg) residues at the 8–9
positions were replaced with two glycines (Gly) (Figure 4A, R8-
9G), or five residues for the 8–12 positions (RRSMK) were
replaced by five Gly (Figure 4A, R8-12G). The subcellular
localization of these mutants was analyzed (Figure S3) and is
summarized in Figure 4A. The results showed that the two
replacement mutants retained Golgi localization, indicating that
sequence specificity of region I was not required. To determine the
minimum requirement of region I to support Golgi localization, a
group of deletion mutants was generated. As summarized in
Figure 4A (and Figure S3), two amino acids in region I,
methionine-lysine (Lys), together with the TMD, were sufficient
to support Golgi localization (Figure 4A, D(2–11)), whereas
methionine alone did not (Figure 4A, GOLPH2-D(I–III–IV–V)).
Lys is a positively charged residue. To determine whether the
nature of its charge at this position is important for Golgi
localization, the first Lys followed by the TMD of GOLPH2-D(2–
11) was replaced with another positively charged Arg or the
negatively charged glutamic acid (Glu). As shown in Figure 4B, the
protein with the LysRArg replacement retained Golgi localization
(Figure 4B, MR-TMD-EGFP), whereas the LysRGlu replacement
lost Golgi localization (Figure 4B, ME-TMD-EGFP). These results
suggested that a positively charged residue followed by the TMD
of GOLPH2 was sufficient for Golgi localization.
GOLPH2 is glycosylated and contains N-linked carbohydrates
(Figure1A). The proper carbohydrate modification of a protein
depends on its correct intracellular localization. Consequently, we
next verified the effect of the positively charged residue at the
cytoplasmic end by comparing the status of their N-linked
carbohydrate modification. The amino acids Lys, Arg, or Glu
were added at the N-terminal of GOLPH2-DI, and the subcellular
localization of these mutants was determined. Consistent with the
above observations, proteins with positively charged residues at the
cytoplasmic end localized to Golgi (MK+GOLPH22DI
MR+GOLPH22DI, Figure 4C), whereas the GOLPH2 mutant
with a negatively charged N-terminal residue did not (ME+-
GOLPH22DI, Figure 4C). After treatment with Endo H and
PNGase F, there was no noticeable difference in GOLPH22DI
and ME+GOLPH22DI. This result suggested that GOLPH22DI
and ME+GOLPH22DI were not modified by N-linked glycosyl-
ation, even though GOLPH22DI was localized in the ER
(Figure 4D). However, similar with GOLPH2-FL, there was a
distinct decrease in molecular weight in MK+GOLPH22DI and
MR+GOLPH22DI after digestion with Endo H and PNGase F.
This finding indicated that both MK+GOLPH22DI and
MR+GOLPH22DI were modified by N-linked glycosylation.
Therefore, the Golgi retention signal is in the TMD of
GOLPH2, and requires a positively charged residue at the N-
terminal cytoplasmic end.
The TMD length is a determinant for GOLPH2 Golgi
localization
Previous studies have revealed that the length of a TMD is
important for its membrane localization. Shorter TMDs of Golgi
proteins prevent them from entering cholesterol-rich transport
vesicles for fusion with the plasma membrane [11,17,18,19]. The
TMD for GOLPH2 is 23 aa long. To explore whether the length
of the TMD for GOLPH2 also influences its intracellular
membrane localization, the hydrophobic residues were shortened
(D(19–25) and D(22–25)) or elongated (Ins(22–24) and Ins(22–27))
in the TMD (Figure 5A). The subcellular localization of these
mutants was then viewed under confocal microscopy. As shown in
Figure 5B, adding three hydrophobic residues (Ins(22–24), 26 aa
long) and deleting four hydrophobic residues (D(22–25), 19 aa
long) did not change the Golgi localization of GOLPH2. However,
when seven hydrophobic residues were deleted (D(19–25), 16 aa
long), the protein dispersed throughout the entire cell. When six
hydrophobic residues were added (Ins(22–27), 29 aa long), some of
the proteins localized to the plasma membrane (Figure 5B, Ins(22–
27)). These results suggested that a 19–26 aa long TMD was
sufficient to maintain Golgi localization, whereas a longer TMD
facilitated transport to the plasma membrane.
GP73 Dimerization and Golgi Localization Signal
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The Golgi localization of many Golgi proteins is maintained by
oligomerization [14,15]. To determine the oligomeric state of
GOLPH2, purified GOLPH2-D(1–55) was analyzed by sodium
dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE).
As shown in Figure 6A, GOLPH2-D(1–55) migrated to higher
bands at around 150 kDa under non-reducing conditions, but was
concentrated mainly to the lower 55 kDa band under reducing
Figure 3. The TMD and cytoplasmic tail of GOLPH2 determine its Golgi localization. A. Subcellular localization of GOLPH2
truncation proteins in HeLa cells. Recombinant proteins transiently expressed in HeLa cells were stained with anti-FLAG mAb, which emits red
fluorescence. Subcellular localization was imaged using a confocal microscope. b-1,4-galactosyltransferase (GalT) fused with cyan fluorescent protein
was cotransfected as a Golgi localization marker (shown as a green pseudocolor). Merged images show the colocalization of GOLPH2 truncation
proteins and GalT. Bars, 10 mm. B. The TMD and cytoplasmic tail of GOLPH2 were sufficient for Golgi localization. HeLa cells were
transfected with GOLPH2-D(III–IV–V), GOLPH2-D(I–III–IV–V), and pEGFP. About 24 h after transfection, cells were treated for 4 h with cycloheximide
(100 mg/mL) to inhibit protein synthesis prior to fixation and permeabilization. Subcellular localization was imaged using a confocal microscope.
Endogenous GOLPH2 was probed using anti-GOLPH2 mAb as a Golgi localization marker (red fluorescence). Merged images were analyzed using the
Leica confocal software. Bars, 10 mm. C. Deletion of region I resulted in ER localization. GOLPH2-D(III–IV–V), GOLPH2-D(I–III–IV–V), GOLPH2-DI,
and pEGFP were transfected into HeLa cells. Subcellular localization was imaged using a confocal microscope. Calreticulin was probed as an ER
marker protein (red fluorescence).
doi:10.1371/journal.pone.0028207.g003
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(Figure 6B), secreted GOLPH2 in human urine (Figure 6C) and
HeLa culture supernatant (Figure 6D) was also analyzed by SDS-
PAGE and immunoblotting. In each case, the apparent molecular
weight under non-reducing conditions was 2–3-fold greater than
under reducing conditions. The addition of the reducing agent 2-
mercaptoethanol dramatically altered the electrophoretic pattern
by promoting the extensive dissociation of oligomers. These results
indicated that both the endogenous and secreted forms of
GOLPH2 existed as oligomers under non-reducing conditions.
GOLPH2 is rich in acidic residues, and has a calculated
isoelectric point of 4.9. Hence, migration is slower in Laemmli-
SDS-PAGE because of the weaker binding to SDS [20].
Consequently, whether GOLPH2 oligomer is a dimer or a trimer
could not be determined by the apparent molecular weight.
Analysis of the protein sequences of GOLPH2 homologs revealed
Figure 4. The Golgi localizing signal is in the TMD, and requires a positively charged residue. A. Summary of fusion proteins used in
the current study and their properties in cellular localization. The amino acid sequences of mutants corresponding to the cytoplasmic
domain and their cellular localization are indicated. Replacement mutants are shown above, and deletion mutants are shown below. B. A positively
charged residue at the cytoplasmic end is important for Golgi retention. The first Lys of D(2–11) was replaced with positively charged Arg
or negatively charged Glu. The mutant plasmids were transfected into HeLa cells, and cellular localizations were imaged using an indirect
immunofluorescence microscope. Endogenous GOLPH2 was detected using anti-GOLPH2 mAb as a Golgi localization marker (red fluorescence).
Merged images reveal the colocalization of endogenous GOLPH2 and mutants. Bars, 10 mm. C. A positively charged residue at the cytoplasmic
end assists Golgi localization. Lys, Arg, and Glu were added to the N-terminal of GOLPH2-DI, and the subcellular localization of these mutants was
imaged using a confocal microscope. GalT was used as a Golgi marker and shown as green fluorescence. D. Endoglycosidase Digestion Assay of
GOLPH2 mutants. GOLPH2 mutants were transfected into HeLa cells, which were then harvested 48 h after transfection and lysing. The cell lysates
were denatured and digested with 500 U Endo H or PNGase F for 3 h at 37uC. The molecular weight marker is shown on the left. U: untreated; H:
treated with Endo H; F: treated with PNGase F.
doi:10.1371/journal.pone.0028207.g004
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(Figure 7A). To determine the composition of the GOLPH2
complex (dimer or trimer), the contributions of the two cysteines
(C159 and C170) in the formation of GOLPH2 oligomer were
analyzed. Cysteines were replaced with alanines individually
(C159A or C170A) or together (C159A and C170A). The
Figure 5. The length of hydrophobic amino acids in the TMD is important for GOLPH2 Golgi retention. A. Mutations used in the
present study. Hydrophobic residues were deleted from or added to the TMD of GOLPH2-D(III–IV–V), and the amino acid sequences of the mutants
are indicated. B. Cellular localizations of fusion proteins. The mutant plasmids were transfected into HeLa cells, and cellular localizations were
viewed using a confocal microscope. Endogenous GOLPH2 was probed by anti-GOLPH2 mAb as a Golgi localization marker (red fluorescence).
Merged images show the colocalization of endogenous GOLPH2 and mutants. Bars, 10 mm.
doi:10.1371/journal.pone.0028207.g005
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into HeLa cells, and the expressed proteins were resolved by SDS-
PAGE under non-reducing conditions, followed by immunoblot-
ting. The single mutants (C159A or C170A) migrated to the same
position of high molecular weight as wild-type GOLPH2
(Figure 7B). However, the double mutant (C159A and C170A)
appeared as a monomer (Figure 7B). Similarly, purified GOLPH2-
D(1–55) and the mutated forms expressed in Escherichia coli showed
the same migration pattern (Figure 7C). These results suggested
that both cysteines were involved in the formation of disulfide
bonds in the complex, and that the arrangements of the disulfide
bonds were C159-C159 and C170-C170. Such disulfide bond
conformation was only possible when GOLPH2 existed as a
dimer.
The coiled-coil domain is sufficient to mediate GOLPH2
dimerization
To investigate the nature of GOLPH2 dimerization, purified
GOLPH2-D(1–55) and its cysteine mutants were analyzed by
native-PAGE. As shown in Figure 8A, the mutated GOLPH2-
D(1–55) had the same migration pattern as the wild-type form,
even after the proteins were denatured by boiling in SDS and 2-
mercaptoethanol. This finding indicated that disulfide bonds were
not necessary in the dimerization of GOLPH2.
To identify the structural determinant for the dimerization of
GOLPH2, GOLPH2-D(IV–V) (amino acids 1–205), GOLPH2-
D(I–II–IV–V) (amino acids 56–205), and GOLPH2-D(I–II–III)
(amino acids 206–401) were co-transfected in HeLa cells with full
length GOLPH2 (without FLAG tag) respectively. Co-immuno-
precipitation assay using an anti-FLAG antibody followed.
GOLPH2 co-precipitated with GOLPH2-D(IV–V) and
GOLPH2-D(I–II–IV–V), but neither reaction was observed with
GOLPH2-D(I–II–III) nor control plasmid pCR3.1-FLAG
(Figure 8A). These results indicated that the coiled-coil domain
(region III) is responsible for GOLPH2 dimerization.
A yeast two-hybrid assay was used to fine-map the regions
required for GOLPH2 dimerization. As shown in Figure 8B, the
coiled-coil domain (region III) of GOLPH2 was subdivided into
Figure 6. GOLPH2 forms disulfide bond-linked oligomers. A, GOLPH2-D(1–55) was purified by Ni-NTA affinity chromatography, and then
boiled to a final concentration of 0 mM to 100 mM 2-mercaptoethanol. Separation by 10% SDS-PAGE followed. GOLPH2 oligomers dissociated with
increased 2-mercaptoethanol. B, The HeLa cell lysates were boiled in the presence of 0 mM or 140 mM 2-mercaptoethanol. Samples were separated
by 8% SDS-PAGE, and analyzed by immunoblotting with GOLPH2 antibody. C and D, Secreted GOLPH2 from normal human urine (C) and HeLa cell
supernatant (D) were prepared under non-reducing and reducing conditions (140 mM 2-mercaptoethanol). Immunoblotting revealed oligomer
formation under non-reducing conditions.
doi:10.1371/journal.pone.0028207.g006
Figure 7. GOLPH2 forms a dimer. A, A partial amino acid sequence of the coiled-coil domain of human GOLPH2 was aligned with the sequences
of the GOLPH2 proteins of different species: Pan troglodytes (XP_520104), Macaca mulatta (XP_001105085), Bos Taurus (XP_595216), Mus musculus
(NP_001030294), Gallus gallus (XP_425035), Xenopus laevis (NP_001087874), and Danio rerio (NP_956573). The two cysteines are shaded gray. B, Wild-
type GOLPH2 and the mutated forms were analyzed by SDS-PAGE: wild-type GOLPH2 (Line 1), single mutant C159A (Line 2), C170A (Line 3), and
double mutant C159A-C170A (Line 4). HeLa cells were transfected with pCR3.1-GOLPH2-FLAG or the mutant forms. About 36 h post-transfection, the
cell lysates were analyzed by SDS-PAGE under non-reducing conditions. The bands were detected by immunoblotting with FLAG antibody. C, Wild-
type GOLPH2-D(1–55) and the mutants were affinity purified and resolved by SDS-PAGE under non-reduced conditions.
doi:10.1371/journal.pone.0028207.g007
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and III-B (amino acids 153–205 containing the two cysteines for
the disulfide bonds). Truncated GOLPH2 was subcloned into both
pGBKT7 and pGADT7 to create a Gal4 DNA binding domain
and activation domain fusion proteins, respectively. These
constructs were not self-activating and could be stably expressed
in the yeast (data not shown).
As presented in Table 2, each Gal4 fusion protein was tested for
its interaction with the activation domain fusion proteins. Strong
interactions (++) were indicated when colonies formed on SD/-
Trp/-Leu/-His/-Ade plates. Weak interactions (+) were indicated
when colonies only formed on SD/-Trp/-Leu/-Ade plates
supplemented with 1 mM 3-AT at 30uC for 3 d to 8 d. As
predicted, the secreted form of GOLPH2-D(1–55) interacted with
itself in the yeast. Interestingly, GOLPH2-IIIA also interacted with
itself in addition to GOLPH2-III–IV–V, indicating that
GOLPH2-IIIA was capable of dimerization. However, the
GOLPH2-IIIB did not interact with any other truncated form of
GOLPH2. These results confirmed that the coiled-coil domain
was sufficient to mediate GOLPH2 dimerization, and that the
interaction region was located between amino acids 56–152.
Discussion
Two mechanisms have been proposed for Golgi localization,
namely, the bilayer-thickness and oligomerization models [14,15].
In the present study, we demonstrated that both endogenous
GOLPH2 and the secreted GOLPH2 (sGOLPH2) exist as a
disulfide-bonded dimer. We then demonstrated that the coiled-coil
domain of GOLPH2 was sufficient to mediate the dimerization of
GOLPH2. We also provided evidence that GOLPH2 dimeriza-
tion was not required for Golgi localization. Instead, the GOLPH2
Golgi localizing signals were the TMD and N-terminal cytoplas-
mic domain.
As a type II Golgi resident glycoprotein, GOLPH2 shares many
structural features with Golgi glycosyltransferase, including a short
N-terminal cytoplasmic domain, a single-pass TMD, and a
relatively longer C-terminal Golgi luminal region. The Golgi
targeting mechanism has been studied more extensively in Golgi
glycosyltransferases than in type II glycoproteins. These studies
have shown that the TMD has a major effect on Golgi localization
[11,12,13,14,15,21]. However, given that many of these enzymes
exist in protein complexes, the actual targeting signals may
probably reside in other members of the complex, rather than in
Figure 8. The coiled-coil domain is sufficient to mediate the formation of GOLPH2 dimer. A, The purified-wild type GOLPH2 (Line 1),
single mutants C159A (Line 2), C170A (Line 3), and double mutants C159A–C170A (Line 4) were analyzed by native-PAGE. Samples were loaded
directly on the gel or boiled with additional 2% SDS and 140 mM 2-mercaptoethanol. The BSA monomer, dimer, and tetramer forms were used as
markers. B, The plasmids encoding GOLPH2-D(IV–V) (amino acids 1–205), GOLPH2–D(I–II–IV–V) (amino acids 56–205), and GOLPH2–D(I–II–III) (amino
acids 206–401) were co-transfected with pCR3.1-GOLPH2-FL and expressed in HeLa cells (input). Cell lysates were captured with anti-FLAG antibody,
and precipitated by Protein G Plus/Protein A agarose. The immunoprecipitates were analyzed by immunoblotting with GOLPH2 antibody. C. The
coiled-coil domain of GOLPH2 was subdivided into two parts: III-A (amino acids 56–152) and III-B (amino acids 153–205). Each fragment of GOLPH2
was cloned into pGBKT7 and pGADT7. A six-glycine linker was inserted between them and the GAL4 DNA binding (or activation) domain.
doi:10.1371/journal.pone.0028207.g008
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the GOLPH2 cytoplasmic and transmembrane domains fused
with EGFP was Golgi localized. This finding suggested that
regions I and II contained Golgi localizing signals, in contrast to
the conclusion of Puri et al. They suggested that the coiled-coil
domain was the Golgi-targeting signal. This suggestion was based
on the observation that a fusion protein with the cytoplasmic tail
and the TMD of DPPIV and the GOLPH2 coiled-coil domain
remained Golgi localized [22]. This discrepancy may be explained
by our second observation, showing that GOLPH2 was a dimer
via coiled-coil domain interactions. Hence, it is possible that the
recombinant protein generated by Puri et al. was localized to the
Golgi through oligomerization with endogenous GOLPH2.
In analyzing the region I mutants, a number of interesting
features of the cytoplasmic tail were revealed. First, most of the
cytoplasmic tail was dispensable for GOLPH2 Golgi localization.
The polypeptide M
1-S
10 does not exist in the isoform-2 of
GOLPH2 (UniProt # QBNBJ4, M
11 is used as the starting
cordon). Hence, our results provided direct evidence that both
isoforms 1 and 2 of GOLPH2 were capable of Golgi membrane
localization. Second, earlier observations have signified that the
TMD flanking residues at the cytoplasmic side are usually
positively charged to assist the orientation of the protein as well
as the steady interaction between the TMD and the negatively
charged proteoglycan in the Golgi membrane. Consistent with this
finding, we found that GOLPH2 isoform-2, which contains only
two residues (MK) in its cytoplasmic side, required at least one
positively charged residue. Replacing Lys with the negatively
charged Glu diminished its Golgi localizing capacity. However,
this was not necessary for GOLPH2 isoform-1, because replacing
R
8RSMK
12 with G
8GGGG
12 (Figure 4A, R8-9G) caused it to
remain Golgi localized.
The TMD as a Golgi retention signal has first been found in a-
2,6-sialyltransferase [13,23]. Subsequently, the bilayer thickness
model is introduced to explain Golgi localization [14,21,24]. This
model is based on the observations that Golgi proteins generally
have shorter TMDs than plasma membrane proteins. On the
other hand, the lipid bilayer increases in thickness from the ER
through the Golgi to the plasma membrane due to increasing
concentrations of cholesterol and sphingolipids. The cholesterol
also changes the bilayer properties, which augment the energetic
penalty for incorporating short TMDs into cholesterol-enriched
domains [24]. As a result, TMD lengthening leads to increased cell
surface expression. Evidence presented in the present study
supported this theory. We found that shortening the GOLPH2
TMD to 19 aa or elongating it to 26 aa did not affect its Golgi
localization. However, when the length was increased to 29 aa, the
protein became partially localized to the plasma membrane.
Bachert et al. have reported that upregulated intracellular
GOLPH2 expression enhanced its intracellular trafficking, most
likely via an endosomal pathway[10]. This phenomenon resulted
in the secretion of a cleaved truncated GOLPH2. In the present
study, GOLPH2-DI, GOLPH2-D(I–II), and GOLPH2-D(I–V),
which lost Golgi localization, failed to traffic and secrete normally
as GOLPH2-FL and GOLPH2-DV did. This evidence suggested
that the intracellular trafficking and secretion of GOLPH2 was
closely related to its Golgi localization.
Another interesting observation came from GOLPH2-D(I–III–
IV–V), a protein with its cytoplasmic tail completely removed. In
transiently transfected cells, some of the proteins were seemingly
nuclear membrane localized (Figure 3B, GOLPH2-D(I–III–IV–
V)). This observation was not found in the other cytoplasmic tail-
deleted mutant (Figure 3A, GOLPH2-DI). The difference may be
attributed to the domain following the TMD, but further
investigation is needed.
The two cysteines C159 and C170 (human GOLPH2) are
conserved among the orthologs of GOLPH2. Hence, the observed
formation of inter-protein disulfide bonds between these cysteines
in the present study was intriguing; these covalent linkages were
not required for GOLPH2 dimer formation. These findings
suggested that the disulfide bonds only served to provide covalent
links to stabilize the dimer, whereas hydrophobic interactions
between the coiled-coil domains are the major forces in protein-
protein interactions. Indeed, our Y2H experiments indicated that
GOLPH2-IIIB, the portion that did not contain cysteines, was
capable of mediating GOLPH2 complex formation. We have
recently identified clusterin as one of the proteins interacting with
GOLPH2 through the coiled-coil domain of GOLPH2 [25]. In
the current study, we have also observed coiled-coil domain-
dependent higher-order oligomerized GOLPH2 using dynamic
light scattering and immunoblotting experiments. These observa-
tions further suggested that the highly conserved coiled-coil
domain of GOLPH2 was a major structure determinant of the
protein. The biological importance of these structural features,
including the highly conserved two cysteines, is yet to be
discovered.
In summary, our study indicated that the TMD is the structure
determinant for GOLPH2 Golgi localization and trafficking, and
that the coiled-coil domain of GOLPH2 may assist Golgi
localization via oligomerization. We thereby propose a structure
model of GOLPH2 (Figure 9). Based on this model, regardless of
the biological function that GOLPH2 may perform, GOLPH2
Table 2. Mapping the binding region of GOLPH2.
pGADT7-GOLPH2
III-A III-B III IV V III-IV-V
pGBKT7-GOLPH2 III-A + + + +
III-B
III
IV
V
III-IV-V + + + +
Each of the gal4 binding domain fusion proteins of truncated GOLPH2 were tested for their interaction with the activation domain fusion proteins to truncated GOLPH2.
Strong interactions (++) are indicated by growth on SD/-Trp/-Leu/-His/-Ade plates, while weak interactions (+) are indicated by growth on SD/-Trp/-Leu/-Ade plates with
1 mM 3-amino-124-triazole (3-AT).
doi:10.1371/journal.pone.0028207.t002
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taken into account when analyzing interactions between GOLPH2
and its interacting partners, such as clusterin [25]. Interestingly,
the sequences in regions I, II, and III are also highly conserved.
This finding suggests that besides being responsible for intracel-
lular localization and dimer formation, these regions may also be
important for the biological function. Nevertheless, although more
structural details of GOLPH2 remain to be clarified (including the
protein crystal structure), the current model indicates that the
secreted GOLPH2, a potential hepatocellular cancer serum
marker, is a dimer. This knowledge could be valuable in the
development of GOLPH2-based diagnostic methods, and in future
structure-function studies.
Materials and Methods
Cell Culture
HeLa cell (ATCC, CCL-2) monolayers were maintained in the
exponential growth phase in Dulbecco’s modified Eagle’s medium
(Gibco, USA) supplemented with 10% fetal bovine serum
(Hyclone, USA), 100 units/mL penicillin, and 0.1% (w/v)
streptomycin.
Plasmid Construction, Mutagenesis, and Protein
Expression
The full-length cDNA of human GOLPH2 was generated by
RT-PCR from the total RNA of Huh7 cells (a gift from Dr. Wong-
Staal, UC-San Diego). Based on the predicted secondary structure
and the level of sequence conservation, we divided GOLPH2 into
five regions. As shown in Figure 1B, different GOLPH2 regions
were amplified by PCR and cloned into the pCR3.1 vector
(Invitrogen,USA) with an in-frame FLAG tag encoded at the C-
terminus. A BamH I site was introduced into GOLPH2-D(IV–V)
and GOLPH2-DI according to the Quickchange protocols
(Stratagene, USA) using the forward primer 5 `-GAGCTCC-
CGGAGCGTGGATCCCTCCAGACACGGATCAT-3 ` (reverse
compliment primers are not shown). The EGFP coding region was
cloned into GOLPH2-D(IV–V) and GOLPH2-DI in site with
BamH I and EcoR I to generate GOLPH2-D(III–IV–V) and
GOLPH2-D(I–III–IV–V) mutants. Mutants based on GOLPH2-
D(III–IV–V) and GOLPH2-D(I–III–IV–V) were constructed
based on the manufacturer’s instructions (Stratagene, USA). The
cysteines at positions 159 and 170 in the coiled-coil domain of
GOLPH2 were mutated to alanines using a QuickChange site-
directed mutagenesis kit (Stratagene). Three different mutants
were created for GOLPH2 in pCR3.1-uni and GOLPH2-D(1–55)
in pET22b (+), including C159A, C170A, and C159A-C170A. All
constructs were verified by sequencing. The GOLPH2-D(1–55)
fusion protein and mutated forms (C159A, C170A, and C159A-
C170A) were expressed in E. coil BL21 (DE3), and purified by Ni-
NTA affinity chromatography (Qiagen) according to the manu-
facturer’s instructions.
Flow Cytometry and Confocal Microscopy
For flow cytometry analysis, cells were harvested using 0.25%
trypsin with EDTA (Gibco, USA) 48 h after transfection. The cells
were thrice washed with cold phosphate-buffered saline (PBS). Cell
suspensions (1610
6 cells/mL) were incubated with anti-FLAG
monoclonal antibody M2 (Sigma, USA) for 30 min on ice,
followed by three washes in PBS. The cells were then incubated
for 30 min on ice with fluorescein isothiocyanate-conjugated sheep
anti-mouse immunoglobulin (Chemicon, USA), and analyzed
using a FACSCalibur analog analyzer (Becton Dickinson) by the
standard protocol.
For confocal microscopy, cells were seeded onto cover slides
24 h after transfection. After overnight culture, some slides were
directly fixed in 4% paraformaldehyde in PBS for 15 min,
followed by permeabilization with 0.5% Triton X-100. These
cells were then stained in diluted antibodies. Other slides were first
treated for 4 h in cycloheximide (100 mg/mL) to inhibit protein
synthesis prior to fixation, followed by antibody staining. The
FLAG epitope in the fusion proteins was detected using anti-
FLAG monoclonal antibody M2 (Sigma, USA), followed by sheep
anti-mouse immunoglobulin conjugated to fluorescein isothiocya-
nate (Chemicon, USA). Endogenous GOLPH2 was detected using
an anti-GOLPH2 monoclonal antibody, as previously described
[5], and a sheep anti-mouse immunoglobulin conjugated to
rhodamine (Chemicon, USA). The cells were then incubated for
Figure 9. A proposed model of a GOLPH2 dimer. We speculate that both endogenous and secreted GOLPH2 are dimerized through the center
of the coiled-coil domain (amino acids 56–152). The monomers are linked by disulfide bonds (C
159-C
159 and C
170-C
170). The gray area shows the
conserved sequence. Five potential locations of N- and O-linked glycosylation sites are also shown.
doi:10.1371/journal.pone.0028207.g009
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viewed using a confocal microscope (TCS SP2 AOBS, Leica,
Switzerland).
Immunoprecipitation
HeLa cells were transfected with expression vectors. After 36 h,
extracts were prepared by collecting a confluent 6-well plate of
HeLa cells into 150 mL of 1% Triton-X100 lysis buffer (pH 7.3
20 mM HEPES, 100 mM KCl, 5 mM EDTA, and 1% Triton X-
100). The cells were incubated for 20 min at 4uC with gentle
agitation. The lysates were centrifuged at 13 0006g for 20 min at
4uC. Anti-FLAG antibody M2 (2 mg, Sigma) was added to the
supernatant, which was incubated overnight at 4uC. About 30 mL
of a 50% suspension of protein A/G beads (Calbiochem) was
added to the supernatant, which was incubated for 2 h at 4uC.
The beads were washed five times with the wash buffer (pH 7.3
20 mM HEPES, 100 mM KCl, 5 mM EDTA, and 0.2% Triton
X-100). Finally, the beads were resuspended in 50 mL of PBS and
boiled with 12 mL of 5X Laemmli sample buffer for 10 min. The
supernatant (25 mL per lane) was analyzed by SDS-PAGE, and the
separated protein bands were transferred onto a polyvinylidene
fluoride membrane (Millipore). The membrane was blocked for
1 h in PBS with 0.05% Tween-20 containing 5% milk, and then
incubated with the antibody as needed. The bound antibodies
were detected with horseradish peroxidase-conjugated rabbit anti-
mouse IgG and enhanced chemiluminescence (Millipore).
Endoglycosidase Digestion Assay
Truncation mutants were transiently transfected into HeLa cells
with Lipofectamine 2000 (Invitrogen) following the manufacturer’s
instructions. About 48 h after transfection, the HeLa cells were
collected and lysed. The cell lysates were denatured in denaturing
buffer (5% SDS and 10% 2-mercaptoethnaol) for 5 min at 100uC,
cooled, and then mixed with Endo H reaction buffer (pH 5.5
0.5 M sodium citrate) or PNGase F reaction buffer (pH 7.5 0.5 M
sodium phosphate and 10% NP-40) at 1 part reaction buffer to 10
parts lysate. The samples were then digested with 500 U Endo H
(NEB, USA) or PNGase F (NEB, USA) for 3 h at 37uC. The
reaction was stopped by adding the sample buffer containing 2-
mercaptoethanol, and the mixture was again incubated at 100uC
for 5 min. Western blot analysis was performed to detect the
digested samples with anti-FLAG mAb (Sigma, USA).
GOLPH2 secretion assay
HeLa cells were transfected with GOLPH2 mutation expression
plasmids. About 24 h post-transfection, the cells were thrice
washed with PBS and cultured in fresh medium. The medium was
collected 24 h later and briefly centrifuged to remove contami-
nating cells. Secreted GOLPH2 was analyzed using a sandwich
ELISA as previously described [5]. In brief, ELISA plates (CoStar,
USA) were precoated with mouse anti-GOLPH2 mAb and
blocked with 2% (w/v) bovine serum albumin. The samples were
incubated for 2 h at room temperature, and were detected by
rabbit anti-GOLPH2 polyclonal antibody, followed by horseradish
peroxidase-conjugated goat anti-rabbit IgG (Pierce, USA). Absor-
bance was measured at 450 nm using a microplate reader (Bio-
Tek, USA).
Liquid chromatography-tandem mass spectrometry (MS/
MS)
Full-length GOLPH2-FLAG was immunoprecipitated from
HeLa cells transfected with the vector expressing GOLPH2-
FLAG. The mixture of proteins was resolved by SDS-PAGE
under non-reducing conditions, and visualized by Coomassie blue
staining. The GOLPH2-FLAG oligomer band was excised, in-gel
digested with trypsin, and analyzed by liquid chromatography-
MS/MS on a ProteomeX-LTQ mass spectrometer (Thermo
Fisher Scientific) according to previously described methods
[26,27] The peptide sequences were identified by a data-
dependent MS/MS model using a SEQUEST algorithm.
Yeast two-hybrid
A yeast two-hybrid (Y2H) assay for protein-protein interactions
was performed following the manufacturer’s instructions (Match-
maker
TM GAL4 Two-Hybrid System 3, Clonetech). A panel of
truncated mutants was subcloned from the C-terminal luminal
region of GOLPH2 (amino acids 56–401) by PCR amplification.
The mutants were inserted into pGBKT7 and pGADT7 with
fusion to the DNA-binding domain and the activation domain,
respectively. A six-Gly linker was added between truncated
GOLPH2 and these domains to increase the fusion protein
flexibility during interaction. Small-scale yeast mating was
performed. AH109 yeast cells pretransformed with truncated
GOLPH2 in pGBKT7 were mated with Y187 yeast cells
pretransformed with truncated GOLPH2 in pGADT7. Mated
yeast cells were spread onto minimal SD agar plates, and positive
clones were screen on SD/-Trp/-Leu/-His/-Ade or SD/-Trp/-
Leu/-Ade plates with 1 mM 3-amino-124-triazole (3-AT, Sigma)
at 30uC for 3 d to 8 d. Mating of AH109 yeast expressing
pGBKT7-53 to Y187 yeast expressing pGADT7-T was performed
as a positive control. Empty vectors pGBKT7 and pGADT7 were
used as negative controls.
Supporting Information
Figure S1 Sequence alignment of GOLPH2 gene. Protein
sequence homologenes of GOLPH2 from different organisms
were aligned. The Pairwise alignment scores and protein access
numbers of NCBI are shown.
(TIF)
Figure S2 Structure prediction of GOLPH2. A, Prediction
of transmembrane helices in GOLPH2 with the TMHMM
program (http://www.cbs.dtu.dk/services/TMHMM/). B, Predic-
tion of coiled-coil regions in GOLPH2 with the Paircoil program
(http://groups.csail.mit.edu/cb/paircoil/cgi-bin/paircoil.cgi).
(TIF)
Figure S3 Cellular localization of fusion proteins with
mutations in the cytoplasmic domain. The mutant plasmids
were transfected into HeLa cells, and cellular localizations were
viewed using a confocal microscope. Endogenous GOLPH2 was
probed using anti-GOLPH2 mAb as a Golgi localization marker,
indicated as red fluorescence. Merged images show the colocaliza-
tion of endogenous GOLPH2 and mutants. Bars, 10 um.
(TIF)
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